UK Markets open in 4 hrs 28 mins

Hofseth BioCare ASA (0Q6H.L)

LSE - LSE Delayed price. Currency in NOK
Add to watchlist
2.0000-6.9000 (-77.53%)
At close: 05:40PM BST
Currency in NOK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.83
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 38.0408
52-week low 38.0408
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8127.04M
% held by insiders 149.37%
% held by institutions 119.33%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Mar 2022


Profit margin -133.20%
Operating margin (ttm)-125.04%

Management effectiveness

Return on assets (ttm)-18.87%
Return on equity (ttm)-78.26%

Income statement

Revenue (ttm)101.56M
Revenue per share (ttm)0.28
Quarterly revenue growth (yoy)82.80%
Gross profit (ttm)13.78M
EBITDA -116.39M
Net income avi to common (ttm)-135.28M
Diluted EPS (ttm)-0.3430
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)30.57M
Total cash per share (mrq)0.09
Total debt (mrq)135.6M
Total debt/equity (mrq)125.55
Current ratio (mrq)0.92
Book value per share (mrq)0.49

Cash flow statement

Operating cash flow (ttm)-52.76M
Levered free cash flow (ttm)-52.78M